TABLE 2.

Summary of safety results in patients with ulcerative colitis.

	Placebo (N = 6)	Selnoflast (N = 13)	All patients (N = 19)
Patients with at least one adverse event (AE)	1 (16.7%)	10 (76.9%)	11 (57.9%)
Total AEs	1	12	13
Deaths	0	0	0
Patients withdrawn from study due to AE	0	0	0
Patients with at least one
AE with fatal outcome	0	0	0
Serious AE	0	0	0
AE leading to withdrawal from treatment	0	0	0
AE leading to dose modification/interruption	0	0	0
Related AE	1 (16.7%)	3 (23.1%)	4 (21.1%)
Related AE leading to withdrawal from treatment	0	0	0
Related AE leading to dose modification/ interruption	0	0	0